Several research works have indicated increase in levels of IL-17 in lung tissues of deceased subjects of steroid-resistant asthma, and this increase in levels of IL-17 has been associated with activation of pathways which trigger inflammatory responses such as constriction of bronchi, increase capillary permeability, edema, and airway hyperreactivity [10, 42]. Here, IL17A is linked to asthma.